nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—obesity—metabolic syndrome X	0.298	0.614	CtDrD
Orlistat—PLA2G7—metabolic syndrome X	0.29	0.721	CbGaD
Orlistat—type 2 diabetes mellitus—metabolic syndrome X	0.187	0.386	CtDrD
Orlistat—PLA2G4A—metabolic syndrome X	0.112	0.279	CbGaD
Orlistat—Ethanolamine Oleate—FABP4—metabolic syndrome X	0.00283	1	CrCbGaD
Orlistat—DAGLB—kidney—metabolic syndrome X	0.00199	0.102	CbGeAlD
Orlistat—Reaction gastrointestinal—Metformin—metabolic syndrome X	0.00191	0.0904	CcSEcCtD
Orlistat—DAGLB—adipose tissue—metabolic syndrome X	0.0018	0.0919	CbGeAlD
Orlistat—PLA2G7—cardiovascular system—metabolic syndrome X	0.00165	0.0842	CbGeAlD
Orlistat—PLA2G7—adipose tissue—metabolic syndrome X	0.00145	0.0743	CbGeAlD
Orlistat—PNLIP—cardiovascular system—metabolic syndrome X	0.00145	0.074	CbGeAlD
Orlistat—ABHD16A—adipose tissue—metabolic syndrome X	0.00136	0.0697	CbGeAlD
Orlistat—Appetite absent—Metformin—metabolic syndrome X	0.00128	0.0606	CcSEcCtD
Orlistat—ABHD12—adipose tissue—metabolic syndrome X	0.00128	0.0653	CbGeAlD
Orlistat—PNLIP—adipose tissue—metabolic syndrome X	0.00128	0.0653	CbGeAlD
Orlistat—DAGLB—liver—metabolic syndrome X	0.00126	0.0645	CbGeAlD
Orlistat—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.00108	0.0513	CcSEcCtD
Orlistat—FASN—adipose tissue—metabolic syndrome X	0.00107	0.0548	CbGeAlD
Orlistat—PLA2G7—liver—metabolic syndrome X	0.00102	0.0521	CbGeAlD
Orlistat—Nail disorder—Metformin—metabolic syndrome X	0.000982	0.0465	CcSEcCtD
Orlistat—Upset stomach—Metformin—metabolic syndrome X	0.000972	0.046	CcSEcCtD
Orlistat—ABHD12—liver—metabolic syndrome X	0.000895	0.0458	CbGeAlD
Orlistat—PNLIP—liver—metabolic syndrome X	0.000895	0.0458	CbGeAlD
Orlistat—Blood disorder—Metformin—metabolic syndrome X	0.000762	0.0361	CcSEcCtD
Orlistat—FASN—liver—metabolic syndrome X	0.000751	0.0384	CbGeAlD
Orlistat—PLA2G4A—cardiovascular system—metabolic syndrome X	0.000584	0.0299	CbGeAlD
Orlistat—PLA2G4A—adipose tissue—metabolic syndrome X	0.000515	0.0263	CbGeAlD
Orlistat—Hypoglycaemia—Metformin—metabolic syndrome X	0.000474	0.0224	CcSEcCtD
Orlistat—Abdominal pain upper—Metformin—metabolic syndrome X	0.000422	0.02	CcSEcCtD
Orlistat—Breast disorder—Metformin—metabolic syndrome X	0.000418	0.0198	CcSEcCtD
Orlistat—Cramp muscle—Metformin—metabolic syndrome X	0.000416	0.0197	CcSEcCtD
Orlistat—Abdominal distension—Metformin—metabolic syndrome X	0.000402	0.0191	CcSEcCtD
Orlistat—Influenza—Metformin—metabolic syndrome X	0.000399	0.0189	CcSEcCtD
Orlistat—Pancreatitis—Metformin—metabolic syndrome X	0.000392	0.0186	CcSEcCtD
Orlistat—Sweating increased—Metformin—metabolic syndrome X	0.000389	0.0184	CcSEcCtD
Orlistat—Abdominal discomfort—Metformin—metabolic syndrome X	0.000383	0.0181	CcSEcCtD
Orlistat—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000371	0.0176	CcSEcCtD
Orlistat—Infestation NOS—Metformin—metabolic syndrome X	0.000356	0.0169	CcSEcCtD
Orlistat—Infestation—Metformin—metabolic syndrome X	0.000356	0.0169	CcSEcCtD
Orlistat—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000349	0.0165	CcSEcCtD
Orlistat—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000337	0.016	CcSEcCtD
Orlistat—Hepatitis—Metformin—metabolic syndrome X	0.00032	0.0152	CcSEcCtD
Orlistat—Oedema peripheral—Metformin—metabolic syndrome X	0.000315	0.0149	CcSEcCtD
Orlistat—Immune system disorder—Metformin—metabolic syndrome X	0.000289	0.0137	CcSEcCtD
Orlistat—Mediastinal disorder—Metformin—metabolic syndrome X	0.000288	0.0137	CcSEcCtD
Orlistat—Malnutrition—Metformin—metabolic syndrome X	0.000278	0.0132	CcSEcCtD
Orlistat—Flatulence—Metformin—metabolic syndrome X	0.000274	0.013	CcSEcCtD
Orlistat—Dysgeusia—Metformin—metabolic syndrome X	0.000273	0.0129	CcSEcCtD
Orlistat—Muscle spasms—Metformin—metabolic syndrome X	0.000268	0.0127	CcSEcCtD
Orlistat—Vision blurred—Metformin—metabolic syndrome X	0.000262	0.0124	CcSEcCtD
Orlistat—Ill-defined disorder—Metformin—metabolic syndrome X	0.000258	0.0122	CcSEcCtD
Orlistat—Malaise—Metformin—metabolic syndrome X	0.000251	0.0119	CcSEcCtD
Orlistat—Palpitations—Metformin—metabolic syndrome X	0.000246	0.0117	CcSEcCtD
Orlistat—Myalgia—Metformin—metabolic syndrome X	0.000237	0.0112	CcSEcCtD
Orlistat—Chest pain—Metformin—metabolic syndrome X	0.000237	0.0112	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000235	0.0112	CcSEcCtD
Orlistat—Discomfort—Metformin—metabolic syndrome X	0.000234	0.0111	CcSEcCtD
Orlistat—Oedema—Metformin—metabolic syndrome X	0.000227	0.0108	CcSEcCtD
Orlistat—Infection—Metformin—metabolic syndrome X	0.000226	0.0107	CcSEcCtD
Orlistat—Nervous system disorder—Metformin—metabolic syndrome X	0.000223	0.0106	CcSEcCtD
Orlistat—Skin disorder—Metformin—metabolic syndrome X	0.000221	0.0105	CcSEcCtD
Orlistat—Hyperhidrosis—Metformin—metabolic syndrome X	0.00022	0.0104	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000207	0.00981	CcSEcCtD
Orlistat—Paraesthesia—Metformin—metabolic syndrome X	0.000204	0.00967	CcSEcCtD
Orlistat—Dyspepsia—Metformin—metabolic syndrome X	0.0002	0.00948	CcSEcCtD
Orlistat—Decreased appetite—Metformin—metabolic syndrome X	0.000197	0.00936	CcSEcCtD
Orlistat—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000196	0.00929	CcSEcCtD
Orlistat—Fatigue—Metformin—metabolic syndrome X	0.000196	0.00928	CcSEcCtD
Orlistat—CYP3A4—kidney—metabolic syndrome X	0.000188	0.00964	CbGeAlD
Orlistat—Feeling abnormal—Metformin—metabolic syndrome X	0.000187	0.00887	CcSEcCtD
Orlistat—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000186	0.0088	CcSEcCtD
Orlistat—Urticaria—Metformin—metabolic syndrome X	0.00018	0.00855	CcSEcCtD
Orlistat—Abdominal pain—Metformin—metabolic syndrome X	0.00018	0.00851	CcSEcCtD
Orlistat—Asthenia—Metformin—metabolic syndrome X	0.000163	0.00772	CcSEcCtD
Orlistat—Pruritus—Metformin—metabolic syndrome X	0.000161	0.00762	CcSEcCtD
Orlistat—Diarrhoea—Metformin—metabolic syndrome X	0.000155	0.00737	CcSEcCtD
Orlistat—Dizziness—Metformin—metabolic syndrome X	0.00015	0.00712	CcSEcCtD
Orlistat—Vomiting—Metformin—metabolic syndrome X	0.000144	0.00684	CcSEcCtD
Orlistat—Rash—Metformin—metabolic syndrome X	0.000143	0.00679	CcSEcCtD
Orlistat—Dermatitis—Metformin—metabolic syndrome X	0.000143	0.00678	CcSEcCtD
Orlistat—Headache—Metformin—metabolic syndrome X	0.000142	0.00674	CcSEcCtD
Orlistat—Nausea—Metformin—metabolic syndrome X	0.000135	0.00639	CcSEcCtD
Orlistat—CYP3A4—liver—metabolic syndrome X	0.000119	0.00609	CbGeAlD
Orlistat—PNLIP—Disease—APOE—metabolic syndrome X	1.91e-05	0.000275	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—LPL—metabolic syndrome X	1.9e-05	0.000275	CbGpPWpGaD
Orlistat—PNLIP—Disease—APOA1—metabolic syndrome X	1.88e-05	0.000272	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	1.86e-05	0.000268	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EPHX2—metabolic syndrome X	1.85e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MLXIPL—metabolic syndrome X	1.85e-05	0.000267	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	1.82e-05	0.000263	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—ALB—metabolic syndrome X	1.82e-05	0.000262	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CD36—metabolic syndrome X	1.81e-05	0.000261	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	1.79e-05	0.000258	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—G6PC2—metabolic syndrome X	1.74e-05	0.000251	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.74e-05	0.000251	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IGF2—metabolic syndrome X	1.72e-05	0.000248	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCA1—metabolic syndrome X	1.72e-05	0.000248	CbGpPWpGaD
Orlistat—FASN—Metabolism—SLC2A4—metabolic syndrome X	1.72e-05	0.000248	CbGpPWpGaD
Orlistat—PNLIP—Disease—IRS1—metabolic syndrome X	1.7e-05	0.000246	CbGpPWpGaD
Orlistat—FASN—Disease—APOB—metabolic syndrome X	1.68e-05	0.000243	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARA—metabolic syndrome X	1.68e-05	0.000243	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOB—metabolic syndrome X	1.67e-05	0.000241	CbGpPWpGaD
Orlistat—FASN—Metabolism—GGT1—metabolic syndrome X	1.66e-05	0.00024	CbGpPWpGaD
Orlistat—FASN—Metabolism—GOT1—metabolic syndrome X	1.66e-05	0.00024	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	1.65e-05	0.000239	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AGT—metabolic syndrome X	1.64e-05	0.000238	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AGT—metabolic syndrome X	1.64e-05	0.000238	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—AKT1—metabolic syndrome X	1.64e-05	0.000236	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—AKT1—metabolic syndrome X	1.64e-05	0.000236	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AGT—metabolic syndrome X	1.63e-05	0.000235	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL5—metabolic syndrome X	1.63e-05	0.000235	CbGpPWpGaD
Orlistat—PNLIP—Disease—INS—metabolic syndrome X	1.63e-05	0.000235	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.62e-05	0.000234	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—LEP—metabolic syndrome X	1.61e-05	0.000233	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOE—metabolic syndrome X	1.61e-05	0.000233	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—LEP—metabolic syndrome X	1.61e-05	0.000233	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOE—metabolic syndrome X	1.61e-05	0.000233	CbGpPWpGaD
Orlistat—FASN—Disease—LPL—metabolic syndrome X	1.61e-05	0.000232	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	1.6e-05	0.000232	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOE—metabolic syndrome X	1.6e-05	0.000231	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—APOA1—metabolic syndrome X	1.59e-05	0.00023	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—APOA1—metabolic syndrome X	1.59e-05	0.00023	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LPL—metabolic syndrome X	1.59e-05	0.00023	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—APOA1—metabolic syndrome X	1.58e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MTNR1B—metabolic syndrome X	1.54e-05	0.000223	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF2—metabolic syndrome X	1.54e-05	0.000222	CbGpPWpGaD
Orlistat—PNLIP—Disease—SERPINE1—metabolic syndrome X	1.5e-05	0.000216	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—APOB—metabolic syndrome X	1.49e-05	0.000216	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—FABP4—metabolic syndrome X	1.48e-05	0.000214	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IRS1—metabolic syndrome X	1.44e-05	0.000208	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IRS1—metabolic syndrome X	1.44e-05	0.000208	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS3—metabolic syndrome X	1.43e-05	0.000206	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOB—metabolic syndrome X	1.41e-05	0.000204	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HSD11B1—metabolic syndrome X	1.4e-05	0.000203	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARG—metabolic syndrome X	1.39e-05	0.000201	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—INS—metabolic syndrome X	1.38e-05	0.000199	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—INS—metabolic syndrome X	1.38e-05	0.000199	CbGpPWpGaD
Orlistat—FASN—Metabolism—PLA2G4A—metabolic syndrome X	1.37e-05	0.000198	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—INS—metabolic syndrome X	1.36e-05	0.000197	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AGT—metabolic syndrome X	1.36e-05	0.000197	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.36e-05	0.000196	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CD36—metabolic syndrome X	1.35e-05	0.000196	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL2—metabolic syndrome X	1.35e-05	0.000196	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL2—metabolic syndrome X	1.35e-05	0.000196	CbGpPWpGaD
Orlistat—FASN—Disease—APOE—metabolic syndrome X	1.35e-05	0.000195	CbGpPWpGaD
Orlistat—FASN—Metabolism—LPL—metabolic syndrome X	1.35e-05	0.000195	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LEP—metabolic syndrome X	1.33e-05	0.000193	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOE—metabolic syndrome X	1.33e-05	0.000193	CbGpPWpGaD
Orlistat—FASN—Disease—APOA1—metabolic syndrome X	1.33e-05	0.000193	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IGF1—metabolic syndrome X	1.33e-05	0.000192	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IGF1—metabolic syndrome X	1.33e-05	0.000192	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—APOA1—metabolic syndrome X	1.32e-05	0.000191	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—metabolic syndrome X	1.31e-05	0.000189	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.3e-05	0.000188	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	1.29e-05	0.000187	CbGpPWpGaD
Orlistat—FASN—Metabolism—CD36—metabolic syndrome X	1.28e-05	0.000185	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SERPINE1—metabolic syndrome X	1.26e-05	0.000183	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SERPINE1—metabolic syndrome X	1.26e-05	0.000183	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—G6PD—metabolic syndrome X	1.25e-05	0.000181	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ALB—metabolic syndrome X	1.25e-05	0.000181	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.23e-05	0.000178	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HDAC3—metabolic syndrome X	1.22e-05	0.000176	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	0.000174	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.21e-05	0.000174	CbGpPWpGaD
Orlistat—FASN—Disease—IRS1—metabolic syndrome X	1.2e-05	0.000174	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2C—metabolic syndrome X	1.2e-05	0.000174	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NOS3—metabolic syndrome X	1.2e-05	0.000173	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GCKR—metabolic syndrome X	1.19e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LPA—metabolic syndrome X	1.19e-05	0.000172	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IRS1—metabolic syndrome X	1.19e-05	0.000172	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARA—metabolic syndrome X	1.19e-05	0.000172	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—APOA1—metabolic syndrome X	1.18e-05	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PLA2G6—metabolic syndrome X	1.15e-05	0.000167	CbGpPWpGaD
Orlistat—FASN—Metabolism—AGT—metabolic syndrome X	1.15e-05	0.000167	CbGpPWpGaD
Orlistat—FASN—Disease—INS—metabolic syndrome X	1.15e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	1.15e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.15e-05	0.000166	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOA5—metabolic syndrome X	1.14e-05	0.000165	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GHRL—metabolic syndrome X	1.14e-05	0.000165	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—INS—metabolic syndrome X	1.14e-05	0.000165	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOE—metabolic syndrome X	1.13e-05	0.000163	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL2—metabolic syndrome X	1.12e-05	0.000162	CbGpPWpGaD
Orlistat—FASN—Metabolism—APOA1—metabolic syndrome X	1.12e-05	0.000161	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.11e-05	0.00016	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IGF1—metabolic syndrome X	1.1e-05	0.000159	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—metabolic syndrome X	1.09e-05	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.09e-05	0.000157	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CNR1—metabolic syndrome X	1.08e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.08e-05	0.000155	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—TRIB3—metabolic syndrome X	1.06e-05	0.000154	CbGpPWpGaD
Orlistat—FASN—Disease—SERPINE1—metabolic syndrome X	1.06e-05	0.000153	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SERPINE1—metabolic syndrome X	1.05e-05	0.000151	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AKT1—metabolic syndrome X	1.03e-05	0.000149	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AKT1—metabolic syndrome X	1.03e-05	0.000149	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HDAC3—metabolic syndrome X	1.02e-05	0.000147	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	0.000147	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	0.000147	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—metabolic syndrome X	1.01e-05	0.000146	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—metabolic syndrome X	1e-05	0.000145	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF1—metabolic syndrome X	9.87e-06	0.000143	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARG—metabolic syndrome X	9.83e-06	0.000142	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	9.77e-06	0.000141	CbGpPWpGaD
Orlistat—FASN—Metabolism—INS—metabolic syndrome X	9.65e-06	0.000139	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NAMPT—metabolic syndrome X	9.53e-06	0.000138	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	9.48e-06	0.000137	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LIPC—metabolic syndrome X	9.47e-06	0.000137	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GCK—metabolic syndrome X	9.47e-06	0.000137	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—metabolic syndrome X	9.44e-06	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOC3—metabolic syndrome X	9.41e-06	0.000136	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AKT1—metabolic syndrome X	9.39e-06	0.000136	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AKT1—metabolic syndrome X	9.39e-06	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINE1—metabolic syndrome X	9.38e-06	0.000136	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—metabolic syndrome X	9.36e-06	0.000135	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—metabolic syndrome X	9.24e-06	0.000134	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CETP—metabolic syndrome X	9.14e-06	0.000132	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MTNR1B—metabolic syndrome X	9.12e-06	0.000132	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	8.97e-06	0.00013	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—metabolic syndrome X	8.95e-06	0.000129	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TRIB3—metabolic syndrome X	8.89e-06	0.000128	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RBP4—metabolic syndrome X	8.89e-06	0.000128	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—metabolic syndrome X	8.84e-06	0.000128	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SCARB1—metabolic syndrome X	8.75e-06	0.000126	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	8.52e-06	0.000123	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SREBF1—metabolic syndrome X	8.5e-06	0.000123	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—metabolic syndrome X	8.46e-06	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL5—metabolic syndrome X	8.37e-06	0.000121	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HMGCR—metabolic syndrome X	8.26e-06	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT2—metabolic syndrome X	8.26e-06	0.000119	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	7.98e-06	0.000115	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—metabolic syndrome X	7.98e-06	0.000115	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—metabolic syndrome X	7.98e-06	0.000115	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOC3—metabolic syndrome X	7.87e-06	0.000114	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—metabolic syndrome X	7.74e-06	0.000112	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	7.45e-06	0.000108	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCA1—metabolic syndrome X	7.37e-06	0.000106	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—SLC2A4—metabolic syndrome X	7.37e-06	0.000106	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT1—metabolic syndrome X	7.13e-06	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT1—metabolic syndrome X	7.13e-06	0.000103	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—metabolic syndrome X	7.11e-06	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2C—metabolic syndrome X	7.1e-06	0.000103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGT—metabolic syndrome X	7e-06	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CYBA—metabolic syndrome X	6.88e-06	9.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GHRL—metabolic syndrome X	6.73e-06	9.73e-05	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—metabolic syndrome X	6.68e-06	9.65e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—metabolic syndrome X	6.61e-06	9.56e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—metabolic syndrome X	6.56e-06	9.49e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CNR1—metabolic syndrome X	6.38e-06	9.22e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOB—metabolic syndrome X	6.05e-06	8.75e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—metabolic syndrome X	6.01e-06	8.69e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—metabolic syndrome X	6.01e-06	8.69e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—metabolic syndrome X	5.92e-06	8.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LPL—metabolic syndrome X	5.78e-06	8.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—metabolic syndrome X	5.76e-06	8.33e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—metabolic syndrome X	5.55e-06	8.02e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—metabolic syndrome X	5.55e-06	8.02e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—metabolic syndrome X	5.5e-06	7.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CD36—metabolic syndrome X	5.49e-06	7.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF2—metabolic syndrome X	5.21e-06	7.54e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARA—metabolic syndrome X	5.11e-06	7.38e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOB—metabolic syndrome X	5.06e-06	7.32e-05	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—metabolic syndrome X	5.03e-06	7.27e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—metabolic syndrome X	4.98e-06	7.2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AGT—metabolic syndrome X	4.95e-06	7.15e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL5—metabolic syndrome X	4.94e-06	7.14e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—FMO3—metabolic syndrome X	4.86e-06	7.03e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—metabolic syndrome X	4.85e-06	7e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LPL—metabolic syndrome X	4.83e-06	6.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOA1—metabolic syndrome X	4.79e-06	6.92e-05	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—metabolic syndrome X	4.64e-06	6.71e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—metabolic syndrome X	4.6e-06	6.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	4.33e-06	6.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	4.33e-06	6.26e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—metabolic syndrome X	4.22e-06	6.1e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—INS—metabolic syndrome X	4.14e-06	5.98e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGT—metabolic syndrome X	4.13e-06	5.98e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—metabolic syndrome X	4.12e-06	5.95e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	4.07e-06	5.89e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—metabolic syndrome X	4.05e-06	5.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—metabolic syndrome X	4.05e-06	5.86e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOA1—metabolic syndrome X	4e-06	5.79e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—metabolic syndrome X	3.89e-06	5.62e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—metabolic syndrome X	3.79e-06	5.49e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—metabolic syndrome X	3.63e-06	5.25e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IRS1—metabolic syndrome X	3.61e-06	5.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—FABP4—metabolic syndrome X	3.46e-06	5.01e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—INS—metabolic syndrome X	3.46e-06	5e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—metabolic syndrome X	3.41e-06	4.92e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1—metabolic syndrome X	3.35e-06	4.84e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—metabolic syndrome X	3.32e-06	4.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	3.28e-06	4.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—metabolic syndrome X	3.18e-06	4.6e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—metabolic syndrome X	3.04e-06	4.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—G6PD—metabolic syndrome X	2.93e-06	4.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	2.86e-06	4.13e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCKR—metabolic syndrome X	2.79e-06	4.04e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LPA—metabolic syndrome X	2.79e-06	4.04e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	2.7e-06	3.91e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA5—metabolic syndrome X	2.68e-06	3.87e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—metabolic syndrome X	2.56e-06	3.7e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	2.49e-06	3.6e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—metabolic syndrome X	2.36e-06	3.41e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.23e-06	3.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.22e-06	3.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.22e-06	3.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.2e-06	3.19e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.14e-06	3.09e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.05e-06	2.96e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—metabolic syndrome X	2.01e-06	2.9e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.99e-06	2.88e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.94e-06	2.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.94e-06	2.8e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	1.73e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	1.73e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT1—metabolic syndrome X	1.67e-06	2.42e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT1—metabolic syndrome X	1.67e-06	2.42e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—metabolic syndrome X	1.67e-06	2.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—metabolic syndrome X	1.51e-06	2.19e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.42e-06	2.05e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—metabolic syndrome X	1.4e-06	2.02e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.38e-06	1.99e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.35e-06	1.96e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.29e-06	1.86e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.2e-06	1.73e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.16e-06	1.67e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.13e-06	1.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.12e-06	1.62e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—metabolic syndrome X	9.88e-07	1.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—INS—metabolic syndrome X	9.69e-07	1.4e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—metabolic syndrome X	8.89e-07	1.28e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—metabolic syndrome X	8.5e-07	1.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	7.78e-07	1.12e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—metabolic syndrome X	3.91e-07	5.65e-06	CbGpPWpGaD
